Zobrazeno 1 - 10
of 1 337
pro vyhledávání: '"Nosbaum A"'
Autor:
Peter A. Lio, April Armstrong, Jan Gutermuth, Audrey Nosbaum, Howard Sofen, Esther Garcia Gil, Marta Casillas, Sherry Chen, Luna Sun, Evangeline Pierce, Hany Elmaraghy, Zach Dawson, Tiago Torres
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 7, Pp 1929-1943 (2024)
Abstract Introduction Atopic dermatitis (AD) is a chronic inflammatory skin disease for which signs and symptoms have a negative impact on a patient’s quality of life (QoL) and mental health. Here, we assess the impact of lebrikizumab on QoL and me
Externí odkaz:
https://doaj.org/article/f74ec9cd69bd430dbe00e9106d83a5c1
Autor:
Rémi Strizzolo, MD, Julien Seneschal, MD, PhD, Angèle Soria, MD, PhD, Delphine Staumont-Sallé, MD, PhD, Sébastien Barbarot, MD, PhD, Manuelle Viguier, MD, PhD, Marie Jachiet, MD, Audrey Nosbaum, MD, PhD, Aude Clément, MD, Marie Tauber, MD, PhD, Stéphanie Mallet, MD, Aurélie Du-Thanh, MD, PhD
Publikováno v:
World Allergy Organization Journal, Vol 17, Iss 7, Pp 100923- (2024)
In patients with moderate to severe atopic dermatitis (AD) showing an inadequate response to dupilumab 300mg/2weeks, few real-life studies reported the response to alternative regimen maintaining dupilumab.To assess and analyze the response to an inc
Externí odkaz:
https://doaj.org/article/904503b3e2134390a8cb3e8125589bae
Autor:
Colin, L., Tauber, M., Souillet, A.L., Coutier, L., Reix, P., Biermé, P., Nosbaum, A., Braun, C.
Publikováno v:
In Revue Française d'Allergologie November 2024 64(6)
Autor:
Braun, Camille, Badiou, Cédric, Guironnet-Paquet, Aurélie, Iwata, Masashi, Lenief, Vanina, Mosnier, Amandine, Beauclair, Charlotte, Renucci, Emilie, Bouschon, Pauline, Cuzin, Roxane, Briend, Yoann, Patra, Vijaykumar, Patot, Sabine, Scharschmidt, Tiffany C., van Wamel, Willem, Lemmens, Nicole, Nakajima, Saeko, Vandenesh, François, Nicolas, Jean-François, Lina, Gérard, Nosbaum, Audrey, Vocanson, Marc
Publikováno v:
In The Journal of Allergy and Clinical Immunology August 2024 154(2):355-374
Autor:
Strizzolo, Rémi, Seneschal, Julien, Soria, Angèle, Staumont-Sallé, Delphine, Barbarot, Sébastien, Viguier, Manuelle, Jachiet, Marie, Nosbaum, Audrey, Clément, Aude, Tauber, Marie, Mallet, Stéphanie, Du-Thanh, Aurélie
Publikováno v:
In World Allergy Organization Journal July 2024 17(7)
Autor:
Loris Guyénard, Marie Tauber, Sophie Debord-Peguet, Frédéric Berard, Audrey Nosbaum, Florence Hacard, Mariana Castells, Jean-François Nicolas
Publikováno v:
Frontiers in Allergy, Vol 5 (2024)
Empty mast cell syndrome, also named post anaphylaxis mast cell anergy (PAMA), is a temporary state of loss of mast cell responsiveness after a severe immediate hypersensitivity reaction. In this study, we describe a case of PAMA after accidental re-
Externí odkaz:
https://doaj.org/article/e6cd2e054920406dbdc56c2900bddb03
Autor:
Delphine Staumont‐Sallé, Sébastien Barbarot, Jean David Bouaziz, Chan Chan, Claire Clibborn, Aurélie Du‐Thanh, Claire Feeney, Alexandre Lejeune, Laurent Misery, Audrey Nosbaum, Julien Seneschal, Angèle Soria, Fan Zhang
Publikováno v:
JEADV Clinical Practice, Vol 2, Iss 3, Pp 518-530 (2023)
Abstract Background Eosinophilia is common in patients with atopic dermatitis (AD). Abrocitinib, an oral Janus kinase‐1 inhibitor and dupilumab, an anti–interleukin‐4 receptor‐α antibody, are approved for moderate‐to‐severe AD. Dupilumab
Externí odkaz:
https://doaj.org/article/aa94d1740f72494ab514527d99321156
Gene profiling in active dermatitis lesions strengthens the diagnosis of allergic contact dermatitis
Autor:
Lefevre, Marine-Alexia, Nosbaum, Audrey, Mosnier, Amandine, Lenief, Vanina, Salque, Samuel, Pichot, Marie, Maheux, Lea, Bertolotti, Lea, Hacard, Florence, Graveriau, Celine, Zukervar, Pascale, Breton Guitarian, Anne-Laure, Boisleve, Fanny, Elbaz, Michelle, Nicolas, Jean-François, Vocanson, Marc
Publikováno v:
In Journal of the American Academy of Dermatology May 2024 90(5):953-962
Autor:
Jacob P. Thyssen, Thomas Bieber, C. Elise Kleyn, Audrey Nosbaum, Susanne Grond, Helmut Petto, Elisabeth Riedl, Andreas Wollenberg
Publikováno v:
Journal of Dermatological Treatment, Vol 34, Iss 1 (2023)
Background Baricitinib is an oral selective Janus kinase 1/2 inhibitor approved for moderate-to-severe atopic dermatitis (AD) in adults. Objectives To evaluate absolute Eczema Area and Severity Index (EASI) and SCORing of Atopic Dermatitis (SCORAD) o
Externí odkaz:
https://doaj.org/article/5099d3aa9d4a4a06bf314cc7ba25d33b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.